SI-BONE, Inc. (SIBN) Stock Forecast
SIBN analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.67 / 5 from 9 analysts
- Price target
- $25.44 average of analyst targets
- Upside to target
- +29.3% from the latest close
- Next earnings
- November 9, 2026 EPS estimate $-0.13
- 52-week range
- $11.61 – $21.40
SIBN analyst ratings
9 analystsNumber of analysts at each rating.
SIBN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
SIBN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.13 | −$0.17 | −$0.07 | −$0.11 | −16.5% | 8 |
| Current fiscal year (2026) | −$0.40 | −$0.45 | −$0.36 | −$0.44 | +9.7% | 8 |
| Next fiscal year (2027) | −$0.33 | −$0.43 | −$0.23 | −$0.40 | +16.8% | 8 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
SIBN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $55.3M | $55.1M | $55.7M | +13.7% | 9 |
| Current fiscal year (2026) | $232.1M | $231.8M | $232.8M | +15.5% | 9 |
| Next fiscal year (2027) | $268.4M | $264.1M | $275.3M | +15.6% | 9 |
SIBN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
SIBN revenue: reported and forecast
SIBN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.13 | −$0.13 | −$0.13 | −$0.13 | −$0.13 | −1.5% | 1 up · 4 down |
| Current fiscal year (2026) | −$0.43 | −$0.39 | −$0.40 | −$0.40 | −$0.40 | −7.3% | 5 up · 1 down |
| Next fiscal year (2027) | −$0.35 | −$0.33 | −$0.33 | −$0.33 | −$0.33 | −6.3% | 3 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
SIBN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; SIBN beat in 12 of 12.
What analysts expect from SIBN
9 analysts cover SI-BONE; their consensus rating is strong buy (4.67 on a 1–5 scale, where 5 is a strong buy). The average price target is $25.44, 29.3% above the latest close of $19.68. Analysts expect earnings of −$0.40 per share for 2026, +9.7% from a year earlier. For 2027 the average estimate is −$0.33 per share on revenue of $268.4 million. SI-BONE beat the EPS estimate in 12 of the last 12 quarters.
Related: SIBN income statement, SIBN key metrics, SIBN chart. See the SIBN stock overview for the latest quote and news.
SIBN forecast FAQ
What is SI-BONE's price target?
The average analyst price target for SI-BONE is $25.44, 29.3% above the latest close of $19.68.
Is SI-BONE a buy, hold or sell?
Of 9 analysts covering SI-BONE, 6 rate it a strong buy, 3 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is SI-BONE's EPS forecast?
Analysts forecast −$0.40 per share for 2026 (range −$0.45 to −$0.36); for 2027 the estimate is −$0.33.
What is SI-BONE's revenue forecast?
The average revenue estimate for 2026 is $232.1 million, growth of 15.5%; for 2027 it is $268.4 million.
When does SI-BONE report earnings?
SI-BONE is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 after the market closes; the EPS estimate is $-0.13.
Does SI-BONE usually beat earnings estimates?
SI-BONE reported EPS at or above the analyst estimate in 12 of the last 12 quarters.